Roth Capital Upgrades Regeneron Pharma (REGN) to Buy
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $810.24 --0%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 6 | New: 10
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 6 | New: 10
Join SI Premium – FREE
Roth Capital upgraded Regeneron Pharma (NASDAQ: REGN) from Neutral to Buy with a price target of $555.00.
For an analyst ratings summary and ratings history on Regeneron Pharma click here. For more ratings news on Regeneron Pharma click here.
Shares of Regeneron Pharma closed at $462.95 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Upgrades Solaria Energia y Medio Ambiente SA (SLR:SM) to Buy
- TD Cowen Upgrades BRP Inc. (DOOO) to Buy
- BHP (BHP:LN) (BHP) PT Raised to GBP28.25 at Barclays
Create E-mail Alert Related Categories
UpgradesRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
